发明名称 THERAPEUTIC DRUG FOR DIABETES
摘要 <p>A medicament for preventive and/or therapeutic treatment of diabetes or complications of diabetes which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: &lt;CHEM&gt; wherein X represents a connecting group whose number of atoms in the main chain is 2 to 5 (said connecting group may be substituted), A represents hydrogen atom or acetyl group, E represents an aryl group which may be substituted or a hetero aryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above.</p>
申请公布号 EP1510207(A1) 申请公布日期 2005.03.02
申请号 EP20030730841 申请日期 2003.06.05
申请人 INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. 发明人 MUTO, SUSUMU;ITAI, A.
分类号 A61K31/055;A61K31/121;A61K31/15;A61K31/166;A61K31/167;A61K31/17;A61K31/18;A61K31/185;A61K31/194;A61K31/216;A61K31/222;A61K31/235;A61K31/275;A61K31/341;A61K31/357;A61K31/36;A61K31/381;A61K31/40;A61K31/403;A61K31/4035;A61K31/44;A61K31/4402;(IPC1-7):A61K31/055;A61K31/404 主分类号 A61K31/055
代理机构 代理人
主权项
地址